Synthetic Mucin Gels with Self-Healing Properties Augment Lubricity and Inhibit HIV-1 and HSV-2 Transmission.


Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
11 2022
Historique:
revised: 14 08 2022
received: 07 07 2022
pubmed: 15 9 2022
medline: 16 11 2022
entrez: 14 9 2022
Statut: ppublish

Résumé

Mucus is a self-healing gel that lubricates the moist epithelium and provides protection against viruses by binding to viruses smaller than the gel's mesh size and removing them from the mucosal surface by active mucus turnover. As the primary nonaqueous components of mucus (≈0.2%-5%, wt/v), mucins are critical to this function because the dense arrangement of mucin glycans allows multivalence of binding. Following nature's example, bovine submaxillary mucins (BSMs) are assembled into "mucus-like" gels (5%, wt/v) by dynamic covalent crosslinking reactions. The gels exhibit transient liquefaction under high shear strain and immediate self-healing behavior. This study shows that these material properties are essential to provide lubricity. The gels efficiently reduce human immunodeficiency virus type 1 (HIV-1) and genital herpes virus type 2 (HSV-2) infectivity for various types of cells. In contrast, simple mucin solutions, which lack the structural makeup, inhibit HIV-1 significantly less and do not inhibit HSV-2. Mechanistically, the prophylaxis of HIV-1 infection by BSM gels is found to be that the gels trap HIV-1 by binding to the envelope glycoprotein gp120 and suppress cytokine production during viral exposure. Therefore, the authors believe the gels are promising for further development as personal lubricants that can limit viral transmission.

Identifiants

pubmed: 36104216
doi: 10.1002/advs.202203898
pmc: PMC9661867
doi:

Substances chimiques

Mucins 0
Gels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2203898

Subventions

Organisme : Swedish Research Council
ID : 2014-6203
Organisme : German Research Foundation
ID : SFB-863

Informations de copyright

© 2022 The Authors. Advanced Science published by Wiley-VCH GmbH.

Références

J Acquir Immune Defic Syndr. 2013 May 1;63(1):120-5
pubmed: 23334506
Biochem Mol Biol Educ. 2004 Jan;32(1):58
pubmed: 21706693
Eur J Immunol. 2011 Dec;41(12):3412-8
pubmed: 22076814
J Virol. 2009 Nov;83(21):11196-200
pubmed: 19692470
NPJ Biofilms Microbiomes. 2018 Jul 4;4:14
pubmed: 30002868
Ann N Y Acad Sci. 2012 Apr;1253:16-36
pubmed: 22524423
Int J Nanomedicine. 2016 May 30;11:2443-50
pubmed: 27313457
ACS Cent Sci. 2022 Mar 23;8(3):351-360
pubmed: 35345395
Biomacromolecules. 2013 Jul 8;14(7):2427-32
pubmed: 23721079
Mucosal Immunol. 2016 Jan;9(1):194-205
pubmed: 26104913
Lancet. 2010 Oct 16;376(9749):1329-37
pubmed: 20851460
Biomolecules. 2020 Apr 20;10(4):
pubmed: 32326134
Mucosal Immunol. 2013 Mar;6(2):427-34
pubmed: 22990624
Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7
pubmed: 6096719
Adv Mater. 2017 Apr;29(14):
pubmed: 28221707
Front Pharmacol. 2019 Oct 16;10:1196
pubmed: 31680970
Clin Dev Immunol. 2012;2012:187585
pubmed: 22548113
Front Chem. 2018 Oct 02;6:449
pubmed: 30333970
Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905
pubmed: 12019106
Front Cell Infect Microbiol. 2021 Jul 13;11:676114
pubmed: 34327149
Adv Sci (Weinh). 2022 Nov;9(32):e2203898
pubmed: 36104216
Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):143-9
pubmed: 22743037
Virol J. 2017 Oct 6;14(1):192
pubmed: 28985745
Nat Rev Microbiol. 2014 Nov;12(11):739-49
pubmed: 25263223
Virol J. 2006 Nov 24;3:99
pubmed: 17125499
Mucosal Immunol. 2014 Sep;7(5):1036-44
pubmed: 24496316
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1482-7
pubmed: 17244708
Cell. 1996 Jun 28;85(7):1135-48
pubmed: 8674119
J Virol. 1998 Apr;72(4):2855-64
pubmed: 9525605
Carbohydr Res. 1986 Aug 15;151:391-402
pubmed: 3768900
Immunology. 2009 Sep;128(1 Suppl):e746-57
pubmed: 19740336
Biomacromolecules. 2012 Jun 11;13(6):1724-32
pubmed: 22475261
FEBS J. 2009 Dec;276(24):7228-36
pubmed: 19878306
Biomater Sci. 2018 Aug 21;6(9):2282-2297
pubmed: 30047553
Biomaterials. 2018 Apr;161:190-202
pubmed: 29421555
AIDS. 2016 Mar 13;30(5):743-51
pubmed: 26605514
Adv Sci (Weinh). 2019 Jun 14;6(16):1801664
pubmed: 31453048
ACS Appl Bio Mater. 2019 Aug 19;2(8):3448-3457
pubmed: 35030733
NCHS Data Brief. 2018 Feb;(304):1-8
pubmed: 29442994
AIDS Res Hum Retroviruses. 2005 Oct;21(10):845-53
pubmed: 16225411
J Exp Med. 1999 Jun 7;189(11):1735-46
pubmed: 10359577
Fertil Steril. 1993 Mar;59(3):617-28
pubmed: 8458467
Mucosal Immunol. 2008 May;1(3):183-97
pubmed: 19079178
J Leukoc Biol. 1997 Jul;62(1):30-3
pubmed: 9225989
Biochem J. 1978 Jul 1;173(1):103-14
pubmed: 28731
ACS Biomater Sci Eng. 2021 Jun 14;7(6):2723-2733
pubmed: 33871978
Science. 1996 May 10;272(5263):872-7
pubmed: 8629022
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4383-8
pubmed: 22392977
J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):16-25
pubmed: 20975570
Nat Rev Microbiol. 2011 Apr;9(4):265-78
pubmed: 21407243
Rev Sci Instrum. 2014 Sep;85(9):093903
pubmed: 25273735
PLoS One. 2011;6(6):e20209
pubmed: 21673796
Nature. 2010 Mar 11;464(7286):217-23
pubmed: 20220840
J Biol Chem. 2000 Mar 24;275(12):8625-32
pubmed: 10722702
Langmuir. 2015 Aug 4;31(30):8303-9
pubmed: 26153254
Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):181-91
pubmed: 22743036
Curr Opin HIV AIDS. 2016 Mar;11(2):156-62
pubmed: 26628324
Cold Spring Harb Perspect Med. 2012 Feb;2(2):a007385
pubmed: 22355798
Chemistry. 2009 Sep 21;15(37):9404-16
pubmed: 19621394
Nature. 1984 Dec 20-1985 Jan 2;312(5996):767-8
pubmed: 6083454
Nature. 1996 Jun 20;381(6584):667-73
pubmed: 8649512
AIDS. 2006 Jan 2;20(1):73-83
pubmed: 16327322
ACS Appl Mater Interfaces. 2020 Apr 29;12(17):19324-19336
pubmed: 32301325
ACS Cent Sci. 2020 Nov 25;6(11):2046-2052
pubmed: 33269329
Nat Rev Immunol. 2007 Apr;7(4):255-66
pubmed: 17380156
Respir Res. 2007 Oct 25;8:73
pubmed: 17961210
Mucosal Immunol. 2018 Sep;11(5):1477-1486
pubmed: 29988116
Mucosal Immunol. 2017 Nov;10(6):1480-1490
pubmed: 28401934
Biomacromolecules. 2021 Apr 12;22(4):1600-1613
pubmed: 33749252
Anal Biochem. 2011 Sep 1;416(1):18-26
pubmed: 21620792

Auteurs

Martin Kretschmer (M)

School of Engineering and Design, Department of Materials Engineering, Technical University of Munich, Boltzmannstrasse 15, 85748, Garching, Germany.
Center for Protein Assemblies, Technical University of Munich, Ernst-Otto-Fischer Str. 8, 85748, Garching, Germany.

Rafael Ceña-Diez (R)

Department of Medicine Huddinge, Division of Infectious Diseases, Karolinska University Hospital, Karolinska Institutet, I73, Stockholm, 141 86, Sweden.

Cosmin Butnarasu (C)

Department of Molecular Biotechnology and Health Science, University of Turin, Turin, 10135, Italy.

Valentin Silveira (V)

Division of Glycoscience, Department of Chemistry, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, AlbaNova University Center, Stockholm, 106 91, Sweden.

Illia Dobryden (I)

Division of Bioeconomy and Health, Department of Material and Surface Design, RISE Research Institutes of Sweden, Malvinas väg 3, Stockholm, SE-114 86, Sweden.

Sonja Visentin (S)

Department of Molecular Biotechnology and Health Science, University of Turin, Turin, 10135, Italy.

Per Berglund (P)

Department of Industrial Biotechnology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, AlbaNova University Center, Stockholm, 106 91, Sweden.

Anders Sönnerborg (A)

Department of Medicine Huddinge, Division of Infectious Diseases, Karolinska University Hospital, Karolinska Institutet, I73, Stockholm, 141 86, Sweden.

Oliver Lieleg (O)

School of Engineering and Design, Department of Materials Engineering, Technical University of Munich, Boltzmannstrasse 15, 85748, Garching, Germany.
Center for Protein Assemblies, Technical University of Munich, Ernst-Otto-Fischer Str. 8, 85748, Garching, Germany.

Thomas Crouzier (T)

Division of Glycoscience, Department of Chemistry, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, AlbaNova University Center, Stockholm, 106 91, Sweden.
AIMES - Center for the Advancement of Integrated Medical and Engineering Sciences at Karolinska Institutet and KTH Royal Institute of Technology, Stockholm, Sweden.
Department of Neuroscience, Karolinska Institutet, Stockholm, SE-171 77, Sweden.

Hongji Yan (H)

Division of Glycoscience, Department of Chemistry, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, AlbaNova University Center, Stockholm, 106 91, Sweden.
AIMES - Center for the Advancement of Integrated Medical and Engineering Sciences at Karolinska Institutet and KTH Royal Institute of Technology, Stockholm, Sweden.
Department of Neuroscience, Karolinska Institutet, Stockholm, SE-171 77, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH